![Utpal Koppikar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Utpal Koppikar
Direktör/Styrelseledamot på
C4 THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-05-31
Profil
Utpal Koppikar is currently an Independent Director at C4 Therapeutics, Inc. since 2022 and Chief Financial Officer at Verily Life Sciences LLC since 2023.
Formerly, Mr. Koppikar was Chief Financial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2018 to 2023, Vice President-Corporate & Operations Finance at Gilead Sciences, Inc. from 2017 to 2018, and Director at Flexion Therapeutics, Inc. in 2021.
Education includes graduate studies at Stanford University, an undergraduate degree from the University of Maryland, and an MBA from UCLA Anderson School of Management.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-22 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Utpal Koppikar
| Företag | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2022-03-16 |
Verily Life Sciences LLC
 Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Finansdirektör/CFO | 2023-04-01 |
Tidigare kända positioner av Utpal Koppikar
| Företag | Position | Slut |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Finansdirektör/CFO | 2023-03-31 |
| FLEXION THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-11-19 |
| GILEAD SCIENCES, INC. | Företagsledare/Principal | 2018-06-01 |
Utpal Koppikars utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
30
Första gradens relationer
8
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UCLA Anderson School of Management
 UCLA Anderson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Verily Life Sciences LLC
Verily Life Sciences LLC Packaged SoftwareTechnology Services Develops tools to collect and organize health data | Technology Services |
C4 Therapeutics, Inc.
 C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
